DK611386A - Recombinant humant fsh, fremgangsmaade til fremstilling deraf og vektorer og celler til anvendelse ved fremgangsmaaden - Google Patents

Recombinant humant fsh, fremgangsmaade til fremstilling deraf og vektorer og celler til anvendelse ved fremgangsmaaden

Info

Publication number
DK611386A
DK611386A DK611386A DK611386A DK611386A DK 611386 A DK611386 A DK 611386A DK 611386 A DK611386 A DK 611386A DK 611386 A DK611386 A DK 611386A DK 611386 A DK611386 A DK 611386A
Authority
DK
Denmark
Prior art keywords
inhibin
recombinant
vectors
procedure
dna
Prior art date
Application number
DK611386A
Other languages
English (en)
Other versions
DK611386D0 (da
DK173446B1 (da
Inventor
Robert Gregory Forage
David Moritz De Kretser
David Mark Robertson
Andrew George Stewart
Original Assignee
Biotech Australia Pty Ltd
Univ Monash
Prince Henrys Hospital
St Vincents Inst Med Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27507359&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK611386(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biotech Australia Pty Ltd, Univ Monash, Prince Henrys Hospital, St Vincents Inst Med Res filed Critical Biotech Australia Pty Ltd
Publication of DK611386D0 publication Critical patent/DK611386D0/da
Publication of DK611386A publication Critical patent/DK611386A/da
Application granted granted Critical
Publication of DK173446B1 publication Critical patent/DK173446B1/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Reproductive Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • General Engineering & Computer Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK198606113A 1985-04-18 1986-12-18 Polynucleotidsekvens, som koder for inhibin DK173446B1 (da)

Applications Claiming Priority (12)

Application Number Priority Date Filing Date Title
AUPH019485 1985-04-18
AUPH019485 1985-04-18
AUPH232085 1985-09-06
AUPH232085 1985-09-06
AUPH315785 1985-10-29
AUPH315785 1985-10-29
AUPH396085 1985-12-19
AUPH396085 1985-12-19
AUPH396185 1985-12-20
AUPH396185 1985-12-20
AU8600097 1986-04-14
PCT/AU1986/000097 WO1986006076A1 (en) 1985-04-18 1986-04-14 Recombinant inhibin

Publications (3)

Publication Number Publication Date
DK611386D0 DK611386D0 (da) 1986-12-18
DK611386A true DK611386A (da) 1987-02-18
DK173446B1 DK173446B1 (da) 2000-11-06

Family

ID=27507359

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198606113A DK173446B1 (da) 1985-04-18 1986-12-18 Polynucleotidsekvens, som koder for inhibin

Country Status (11)

Country Link
US (1) US6613891B1 (da)
EP (1) EP0218717B1 (da)
JP (1) JP3213470B2 (da)
KR (1) KR940004077B1 (da)
CA (1) CA1341619C (da)
DE (1) DE3650689T2 (da)
DK (1) DK173446B1 (da)
IL (1) IL78519A (da)
IN (1) IN165453B (da)
NZ (1) NZ215829A (da)
WO (1) WO1986006076A1 (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341617C (en) * 1984-06-08 2011-06-28 Henry George Burger Inhibin isolated from ovarian follicular fluid
JPH0637520B2 (ja) * 1985-07-03 1994-05-18 味の素株式会社 ポリペプチド
NZ231899A (en) * 1985-10-03 1991-07-26 Genentech Inc Human or porcine inhibin peptide compositions and dna encoding them
US5089396A (en) * 1985-10-03 1992-02-18 Genentech, Inc. Nucleic acid encoding β chain prodomains of inhibin and method for synthesizing polypeptides using such nucleic acid
US5215893A (en) * 1985-10-03 1993-06-01 Genentech, Inc. Nucleic acid encoding the ba chain prodomains of inhibin and method for synthesizing polypeptides using such nucleic acid
NZ219609A (en) * 1986-03-13 1990-09-26 Univ Monash Assay methods for inhibin
CA1305829C (en) * 1986-06-24 1992-07-28 Joachim Spiess Ovine inhibin
WO1989011862A1 (en) * 1988-05-31 1989-12-14 Biotechnology Australia Pty. Ltd. Actions of hormones
US5071834A (en) * 1988-09-16 1991-12-10 Genentech, Inc. Purified activin B composition
US5942220A (en) * 1990-03-16 1999-08-24 Chiron Corporation Inhibitor of cytokine activity and applications thereof
US6297026B1 (en) 1993-07-26 2001-10-02 Cor Therapeutics Inc. Nucleic acids encoding the C140 receptor
AUPO638897A0 (en) * 1997-04-23 1997-05-22 Monash University Modulation of cell growth and methods relating thereto
AU8579298A (en) * 1997-07-31 1999-02-22 Johns Hopkins University School Of Medicine, The Growth differentiation factor-16
US6787311B1 (en) 1999-02-25 2004-09-07 Auckland Uniservices Limited Diagnosis of premature ovarian failure
CA2441699A1 (en) * 2001-04-13 2002-10-24 Boyce Thompson Institute For Plant Research Methods and compositions for stable transgenic plant pharmaceuticals and their use as contraceptives
CN102409065B (zh) * 2011-06-28 2014-05-21 中国农业科学院北京畜牧兽医研究所 一种提高动物繁育力的新型shRNA及其应用
BR102014005376A2 (pt) * 2014-03-07 2016-02-10 Ouro Fino Saúde Animal Ltda antígeno de inibina alfa, gene codificante de inibina alfa, gene codificante de proteína de fusão, processo de obtenção do antígeno de inibina alfa, composição antigênica, uso do antígeno de inibina alfa e uso da composição antigênica
CN105296493B (zh) * 2015-11-13 2020-09-11 北京农学院 一种牛抑制素α亚基成熟肽基因及重组表达蛋白质的方法
CN108588100B (zh) * 2018-05-09 2021-07-16 广州市达瑞生物技术股份有限公司 一种抑制素b双基因片段联合表达载体及其应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4399216A (en) 1980-02-25 1983-08-16 The Trustees Of Columbia University Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
US4717666A (en) 1984-03-05 1988-01-05 Smithkline Beckman Corporation Cloned streptomycete lividans excretable β-galactosidase gene
EP0147445B1 (en) 1983-06-20 1987-11-19 Battelle Development Corporation High-velocity multisolid fluidized bed process
US4643969A (en) 1983-07-25 1987-02-17 The Research Foundation Of State University Of New York Novel cloning vehicles for polypeptide expression in microbial hosts
DE3587022T2 (de) * 1984-02-17 1993-06-17 Genentech Inc Menschlicher transformationswachstumsfaktor und vorlaeufer oder fragment hiervon, zellen, dna, vektoren und verfahren zu ihrer herstellung, zusammensetzungen und produkte, die diese enthalten, sowie davon abgeleitete antikoerper und diagnostizierverfahren.
US4636463A (en) * 1984-04-05 1987-01-13 Scripps Clinic And Research Foundation Antibodies to human interleukin-2 induced by synthetic polypeptides
CA1341617C (en) * 1984-06-08 2011-06-28 Henry George Burger Inhibin isolated from ovarian follicular fluid
JPH0730114B2 (ja) * 1985-04-03 1995-04-05 正雄 五十嵐 インヒビン
US4624944A (en) 1985-06-14 1986-11-25 The Regents Of The University Of California Human seminal alpha-inhibins
US4740587A (en) 1985-07-18 1988-04-26 The Salk Institute For Biological Studies Inhibin and method of purifying same
US4798885A (en) 1986-02-07 1989-01-17 Genentech, Inc. Compositions of hormonally active human and porcine inhibin containing an α chain and 62 chain
NZ231899A (en) * 1985-10-03 1991-07-26 Genentech Inc Human or porcine inhibin peptide compositions and dna encoding them
US4864019A (en) * 1985-11-08 1989-09-05 The Salk Institute For Biological Studies Antibodies to inhibin and conjugates produced therefrom
US4737578A (en) 1986-02-10 1988-04-12 The Salk Institute For Biological Studies Human inhibin
US5011691A (en) 1988-08-15 1991-04-30 Stryker Corporation Osteogenic devices

Also Published As

Publication number Publication date
DK611386D0 (da) 1986-12-18
JPH07188296A (ja) 1995-07-25
US6613891B1 (en) 2003-09-02
JP3213470B2 (ja) 2001-10-02
KR870700633A (ko) 1987-12-30
DK173446B1 (da) 2000-11-06
EP0218717A4 (en) 1990-04-10
IN165453B (da) 1989-10-21
WO1986006076A1 (en) 1986-10-23
DE3650689D1 (de) 1998-08-20
KR940004077B1 (ko) 1994-05-11
IL78519A0 (en) 1986-08-31
EP0218717A1 (en) 1987-04-22
IL78519A (en) 1992-01-15
NZ215829A (en) 1991-11-26
DE3650689T2 (de) 1999-04-08
CA1341619C (en) 2011-08-02
EP0218717B1 (en) 1998-07-15

Similar Documents

Publication Publication Date Title
DK611386A (da) Recombinant humant fsh, fremgangsmaade til fremstilling deraf og vektorer og celler til anvendelse ved fremgangsmaaden
DK532284A (da) Fremgangsmaade til bestemmelse af antigenaktive aminosyresekvenser
ATE49233T1 (de) Vektoren zur transformation von hefe.
ATE319091T1 (de) Diagnose von einheimischer sprue/zöliakie mit hilfe von gliadinepitopen
DE68929043D1 (de) Für androgen-rezeptor-protein kodierende dna
DK150992A (da) Fremgangsmaade til fremstilling af et polypeptidfragment af faktor viii:c, dna-sekvens og ekstrachromosomalt element indeholdende en saadan dna-sekvens, som koder herfor
FI102075B1 (fi) Menetelmä valmistaa glykosyloitu tai glykosyloimaton polypeptidi, rekombinanttinukleiinihappo ja vektorit
ATE73494T1 (de) Antigene proteine und diese enthaltende impfstoffe zur verhuetung von kokzidiose.
DK645887D0 (da) Gamma-hesteinterferon, fremgangsmaade til fremstilling af, samt anvendelse af en saadan forbindelse
GB2143830A (en) Expression of plasmodium falciparum polypeptides from cloned cdna
DK175843B1 (da) Polypeptider af overfladeaktive alvelolarproteiner (ASP), farmaceutisk sammensætning indeholdende polypeptidet, DNA-ekspressionssystem der koder for polypeptidet, samt fremgangsmåde til fremstilling af polypeptider med ASP-aktivitet
ES550943A0 (es) Un procedimiento para preparar una proteina de fusion derivada de la secuencia de aminoacidos de la preprorrelaxina humana.
DK610888A (da) Cardiodilatinfragmentet, fremgangsmaade til fremstilling deraf samt dets anvendelse
GR3018371T3 (en) Method for identifying or determining proteins and applications therefor.
BR9714133A (pt) ácido nucleico isolado, molécula do mesmo, sonda, vetor de expressão recombinante, célula, polipeptìdeo, proteìna de fusão formulação de vacina e processos para produzir um polipeptìdeo de h. pylori, para detctar a presença de um ácido nucleico de helicobacter em uma amostra, para tratar ou reduzir um risco de infecção por h. pylori em um indivìduo e para produzir uma formulação de vacina
ATE327251T1 (de) Methode zur reduzierung der immunogenizität von staphylokinase durch entfernen von t-zell epitopen
NO178504C (no) Fr.måte for fr.stilling av minaktivin,DNA-molekyl,gen,vert,prober,preparat som omfatter prober,reagens for lokalisering og defini. av grenser for tumor i histologiske pröver,samt anvendelse av DNA-molekyl,minaktivin og preparat
ES553374A0 (es) Un procedimiento para mejorar la produccion de un polipeptido deseado en un hospedante transformado con una molecula de adn recombinantes.
DE3877136D1 (de) Rekombinantes histidinreiches protein von plasmodium falciparum, seine herstellung und verwendung.
AU1541395A (en) Folding proteins
DE69012989D1 (de) Peptiden von retinblastoma gen produkten und antikoerper dagegen.
DE3876227D1 (de) Malaria-spezifische dna-sequenzen, ihre expressionsprodukte und deren verwendung.
Kuwayama et al. Porcine Skeletal Muscle Dystrophin
Kostina et al. Determination of Amino Acid Sequences of Large Hydrophobic Peptides of Rhodopsin
FI961398A (fi) Menetelmä terapeuttisesti käyttökelpoisen peptidin valmistamiseksi

Legal Events

Date Code Title Description
ATS Application withdrawn
ATS Application withdrawn
AHB Application shelved due to non-payment
B1 Patent granted (law 1993)
PUP Patent expired